Consistently, absolute numbers of CD44high/CD24−/low sub-population increased by 2.1-fold in SUM190-transplanted mice receiving poly(I:C) injection (Figure 3d), demonstrating that TLR3 activation retards tumor growth but enriches for breast CSCs. This evidence concerns the gene TLR3 and neoplasm.